Department of Bioactive Molecules, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Mol Microbiol. 2011 Oct;82(2):416-33. doi: 10.1111/j.1365-2958.2011.07820.x. Epub 2011 Sep 19.
Members of the pleiotropic drug resistance (PDR) family of ATP binding cassette (ABC) transporters consist of two homologous halves, each containing a nucleotide binding domain (NBD) and a transmembrane domain (TMD). The PDR transporters efflux a variety of hydrophobic xenobiotics and despite the frequent association of their overexpression with the multidrug resistance of fungal pathogens, the transport mechanism of these transporters is poorly understood. Twenty-eight chimeric constructs between Candida albicans Cdr1p (CaCdr1p) and Cdr2p (CaCdr2p), two closely related but functionally distinguishable PDR transporters, were expressed in Saccharomyces cerevisiae. All chimeras expressed equally well, localized properly at the plasma membrane, retained their transport ability, but their substrate and inhibitor specificities differed significantly between individual constructs. A detailed characterization of these proteins revealed structural features that contribute to their substrate specificities and their transport mechanism. It appears that most transmembrane spans of CaCdr1p and CaCdr2p provide or affect multiple, probably overlapping, substrate and inhibitor binding site(s) similar to mammalian ABC transporters. The NBDs, in particular NBD1 and/or the ∼150 amino acids N-terminal to NBD1, can also modulate the substrate specificities of CaCdr1p and CaCdr2p.
多药耐药(PDR)家族的 ABC 转运蛋白成员由两个同源半部分组成,每个半部分包含一个核苷酸结合域(NBD)和一个跨膜域(TMD)。PDR 转运蛋白可排出多种疏水性异生物质,尽管它们的过度表达常与真菌病原体的多药耐药性相关,但这些转运蛋白的运输机制仍知之甚少。在酿酒酵母中表达了 28 种源自白念珠菌 Cdr1p(CaCdr1p)和 Cdr2p(CaCdr2p)的嵌合构建体,这两种转运蛋白密切相关但功能上可区分。所有嵌合体表达水平相当,正确定位于质膜,保留其转运能力,但它们的底物和抑制剂特异性在单个构建体之间存在显著差异。对这些蛋白质的详细特征分析揭示了结构特征,这些特征有助于它们的底物特异性和它们的运输机制。似乎 CaCdr1p 和 CaCdr2p 的大多数跨膜跨度提供或影响多个可能重叠的底物和抑制剂结合位点(类似于哺乳动物 ABC 转运蛋白)。NBD,特别是 NBD1 和/或 NBD1 之前的约 150 个氨基酸,也可以调节 CaCdr1p 和 CaCdr2p 的底物特异性。